Morley Research Consortium (MRC), a dedicated full service contract research organization (CRO) helps early to mid-stage medical device/biotech companies achieve their goals in getting products to commercialization. Our focus is different than most CROs since we only work with companies that are early to mid-stage who require regulatory planning and implementation (medical device and biotech), as well as, phase I – post marketing clinical trials. MRC also currently works with venture capital, angel networks, and foundations to help screen new opportunities that align with funding criteria. Having a solid clinical pathway and partner to bring your product to market is vital to your organization’s success. Look no further than MRC to turn the idea into reality.